Lisdexamfetamine dimesylate
Lisdexamfetamine Dimesylate is a generic prescription medication manufactured by Hikma Pharmaceuticals USA Inc. It's a central nervous system stimulant classified as a DEA Schedule II controlled substance, available in oral capsule form in strengths of 10mg, 20mg, 30mg, 40mg, 50mg, 60mg, and 70mg. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Lisdexamfetamine Dimesylate is a generic prescription medication manufactured by Hikma Pharmaceuticals USA Inc. It's a central nervous system stimulant classified as a DEA Schedule II controlled substance, available in oral capsule form in strengths of 10mg, 20mg, 30mg, 40mg, 50mg, 60mg, and 70mg. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Lisdexamfetamine dimesylate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Lisdexamfetamine dimesylate — ANDA 202802 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202802"
}
]
|
| identifier | ANDA202802 |
| issued | 2016-09-16 |
| keyword |
[
"fda",
"health-care",
"medications",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Lisdexamfetamine dimesylate |
